These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

789 related articles for article (PubMed ID: 35563107)

  • 21. Interplay of RNA-Binding Proteins and microRNAs in Neurodegenerative Diseases.
    Kinoshita C; Kubota N; Aoyama K
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34069857
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular Biomarkers and Their Implications for the Early Diagnosis of Selected Neurodegenerative Diseases.
    Doroszkiewicz J; Groblewska M; Mroczko B
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563001
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preventing amyotrophic lateral sclerosis: insights from pre-symptomatic neurodegenerative diseases.
    Benatar M; Wuu J; McHutchison C; Postuma RB; Boeve BF; Petersen R; Ross CA; Rosen H; Arias JJ; Fradette S; McDermott MP; Shefner J; Stanislaw C; Abrahams S; Cosentino S; Andersen PM; Finkel RS; Granit V; Grignon AL; Rohrer JD; McMillan CT; Grossman M; Al-Chalabi A; Turner MR;
    Brain; 2022 Mar; 145(1):27-44. PubMed ID: 34677606
    [TBL] [Abstract][Full Text] [Related]  

  • 24. miRNAs: Key Players in Neurodegenerative Disorders and Epilepsy.
    Karnati HK; Panigrahi MK; Gutti RK; Greig NH; Tamargo IA
    J Alzheimers Dis; 2015; 48(3):563-80. PubMed ID: 26402105
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Current Status of microRNA-Based Therapeutic Approaches in Neurodegenerative Disorders.
    Paul S; Bravo Vázquez LA; Pérez Uribe S; Roxana Reyes-Pérez P; Sharma A
    Cells; 2020 Jul; 9(7):. PubMed ID: 32679881
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of microRNAs in neurodegenerative diseases: a review.
    Li S; Lei Z; Sun T
    Cell Biol Toxicol; 2023 Feb; 39(1):53-83. PubMed ID: 36125599
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Histone Methylation Regulation in Neurodegenerative Disorders.
    Basavarajappa BS; Subbanna S
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925016
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNAs in amyotrophic lateral sclerosis: from pathogenetic involvement to diagnostic biomarker and therapeutic agent development.
    Wang L; Zhang L
    Neurol Sci; 2020 Dec; 41(12):3569-3577. PubMed ID: 33006054
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum miRNAs miR-206, 143-3p and 374b-5p as potential biomarkers for amyotrophic lateral sclerosis (ALS).
    Waller R; Goodall EF; Milo M; Cooper-Knock J; Da Costa M; Hobson E; Kazoka M; Wollff H; Heath PR; Shaw PJ; Kirby J
    Neurobiol Aging; 2017 Jul; 55():123-131. PubMed ID: 28454844
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dessert or Poison? The Roles of Glycosylation in Alzheimer's, Parkinson's, Huntington's Disease, and Amyotrophic Lateral Sclerosis.
    Yang J; Li H; Zhao Y
    Chembiochem; 2023 Aug; 24(16):e202300017. PubMed ID: 37440197
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Sex Perspective in Neurodegenerative Diseases: microRNAs as Possible Peripheral Biomarkers.
    Piscopo P; Bellenghi M; Manzini V; Crestini A; Pontecorvi G; Corbo M; Ortona E; Carè A; Confaloni A
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33922607
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Research on ferroptosis as a therapeutic target for the treatment of neurodegenerative diseases.
    Wang Y; Lv MN; Zhao WJ
    Ageing Res Rev; 2023 Nov; 91():102035. PubMed ID: 37619619
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Use of Stem Cells as a Potential Treatment Method for Selected Neurodegenerative Diseases: Review.
    Cecerska-Heryć E; Pękała M; Serwin N; Gliźniewicz M; Grygorcewicz B; Michalczyk A; Heryć R; Budkowska M; Dołęgowska B
    Cell Mol Neurobiol; 2023 Aug; 43(6):2643-2673. PubMed ID: 37027074
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biomarkers for Managing Neurodegenerative Diseases.
    Cheslow L; Snook AE; Waldman SA
    Biomolecules; 2024 Mar; 14(4):. PubMed ID: 38672416
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNA: Basic concepts and implications for regeneration and repair of neurodegenerative diseases.
    Saraiva C; Esteves M; Bernardino L
    Biochem Pharmacol; 2017 Oct; 141():118-131. PubMed ID: 28709951
    [TBL] [Abstract][Full Text] [Related]  

  • 36. lncRNA NEAT1: Key player in neurodegenerative diseases.
    Li K; Wang Z
    Ageing Res Rev; 2023 Apr; 86():101878. PubMed ID: 36738893
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeted Delivery for Neurodegenerative Disorders Using Gene Therapy Vectors: Gene Next Therapeutic Goals.
    Singh M; Singh SP; Yadav D; Agarwal M; Agarwal S; Agarwal V; Swargiary G; Srivastava S; Tyagi S; Kaur R; Mani S
    Curr Gene Ther; 2021; 21(1):23-42. PubMed ID: 32811395
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of exercise on sleep in neurodegenerative disease.
    Memon AA; Coleman JJ; Amara AW
    Neurobiol Dis; 2020 Jul; 140():104859. PubMed ID: 32243913
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Panoramic Visualization of Circulating MicroRNAs Across Neurodegenerative Diseases in Humans.
    Brennan S; Keon M; Liu B; Su Z; Saksena NK
    Mol Neurobiol; 2019 Nov; 56(11):7380-7407. PubMed ID: 31037649
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neural stem cell-based treatment for neurodegenerative diseases.
    Kim SU; Lee HJ; Kim YB
    Neuropathology; 2013 Oct; 33(5):491-504. PubMed ID: 23384285
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 40.